Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Long-Term Investments (2022 - 2024)

Vsee Health filings provide 3 years of Long-Term Investments readings, the most recent being $1.4 million for Q1 2024.

  • On a quarterly basis, Long-Term Investments fell 81.76% to $1.4 million in Q1 2024 year-over-year; TTM through Mar 2024 was $1.4 million, a 81.76% decrease, with the full-year FY2023 number at $1.4 million, down 81.82% from a year prior.
  • Long-Term Investments hit $1.4 million in Q1 2024 for Vsee Health, up from $1.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $8.1 million in Q3 2023 to a low of $1.4 million in Q4 2023.
  • Median Long-Term Investments over the past 3 years was $7.6 million (2022), compared with a mean of $5.7 million.
  • Biggest five-year swings in Long-Term Investments: plummeted 81.82% in 2023 and later crashed 81.76% in 2024.
  • Vsee Health's Long-Term Investments stood at $7.5 million in 2022, then plummeted by 81.82% to $1.4 million in 2023, then increased by 1.3% to $1.4 million in 2024.
  • The last three reported values for Long-Term Investments were $1.4 million (Q1 2024), $1.4 million (Q4 2023), and $8.1 million (Q3 2023) per Business Quant data.